Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

3.310

+0.020 (0.61%)

At close: Aug 13, 2026, 4:00 PM EDT

3.300

-0.010 (-0.30%)

After-hours: Aug 13, 2026, 7:54 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Research and Development Agreements Revenue	53.94M	74.26M	58.49M
Grant Revenue	916.00K	425.00K	351.00K
Revenue (Other)	1,000.00	-	-
Revenue (Total)	54.86M	74.68M	58.84M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States Revenue	-	39.34M	57.38M
United Kingdom Revenue	-	35.34M	1.14M
Other Geographic Revenue	-	-	327.00K
Revenue (Total)	54.86M	74.68M	58.84M